USPTO 2015–2025 USPTO PatentsView US Corporation

Corbion Biotech, Inc.

USPTO PatentsView assignee record — 40 granted patents across 33 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

40
Total patents granted
33
CPC technology areas
15.9
Avg claims per patent
-26%
5-year filing velocity

Portfolio overview

Corbion Biotech, Inc. has been granted 40 US utility patents between 2018 and 2025, placing Corbion Biotech, Inc. at rank #8,003 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Corbion Biotech, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 45.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 23 in the 2015–2019 window — a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Corbion Biotech, Inc.'s 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Corbion Biotech, Inc. against peers pursuing similar technology classes.

How does Corbion compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Corbion holds 40 patents — placing it at rank #8,003 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2018–2025

051015 20182019202020212022202320242025 2
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Corbion Biotech, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 10 25.0%
2019 13 32.5%
2020 5 12.5%
2021 2 5.0%
2022 4 10.0%
2023 3 7.5%
2024 1 2.5%
2025 2 5.0%

Which technologies does Corbion Biotech, Inc. patent most?

Top 15 of 33 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#8,003

Across all tracked assignees

Innovation Score

45.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Corbion Biotech, Inc. hold?
Corbion Biotech, Inc. holds 40 US granted patents filed between 2018 and 2025, spanning 33 technology areas.
What is Corbion Biotech, Inc.'s Innovation Score?
Corbion Biotech, Inc. has an Innovation Score of 45.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Corbion Biotech, Inc. focus on?
Corbion Biotech, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 28 patents. The company has filed patents in 33 CPC subclasses total.
Is Corbion Biotech, Inc.'s patent filing rate increasing or decreasing?
Corbion Biotech, Inc.'s recent filing velocity is -26% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Corbion Biotech, Inc.'s patents?
Corbion Biotech, Inc.'s patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Corbion Biotech, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope